MedPath

Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders

Not Applicable
Recruiting
Conditions
Delirium
Implementation Science
Patient Satisfaction
Mild Cognitive Impairment
Alzheimer Disease
Family Support
Family Members
Caregiver Burden
Neurocognitive Disorders
Aging
Interventions
Behavioral: FAM-HELP
Behavioral: HELP
Registration Number
NCT05929703
Lead Sponsor
University of Michigan
Brief Summary

The goal of this clinical trial is to compare the Hospital Elder Life Program (HELP) with a family-augmented version of HELP (FAM-HELP), that includes family members and care partners, for the prevention of delirium in older patients during hospital admission. The main objectives of the trial are the following:

1. To compare the effectiveness of FAM-HELP and HELP in reducing both the incidence of delirium and its severity.

2. To compare the effectiveness of FAM-HELP and HELP in improving patient- and family-reported outcomes.

3. To explore the implementation context, process, and outcomes of the FAM-HELP program in diverse hospital settings.

Detailed Description

Delirium is a common complication of hospitalization and major surgery for older adults, and it can lead to loss of independence and substantial healthcare costs. One approach to preventing delirium is through the Hospital Elder Life Program (HELP). HELP personnel work to prevent delirium by providing orienting communication, assisting patients with walking and exercise, providing help with nutrition and fluids, implementing sleep protocols, and helping patients with vision and hearing aids.

However, it is unknown whether involving family members in these activities along with HELP staff (i.e., "FAM-HELP") might be more effective with preventing delirium. The objective of this clinical trial is thus to compare the traditional HELP program with a family-augmented version of HELP (FAM-HELP) to determine which program is more effective with preventing delirium and related complications in older, hospitalized patients.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
3000
Inclusion Criteria
  • Provision of informed consent
  • At least 70 years of age
  • Anticipated length of hospital stay at least 72 hours
  • Family member or care partner available to be on-site in the hospital
  • At least one delirium risk factor (e.g., cognitive or functional impairment, dehydration, vision or hearing impairment)
  • Evaluable cognitive function at baseline (i.e., ability to complete baseline cognitive function assessment)
Exclusion Criteria
  • Delirium on admission
  • Unable to communicate verbally (e.g., coma, mechanical ventilation)
  • Unable to participate fully in interventions (e.g., terminal condition, advanced dementia)
  • Staff safety concerns (e.g., violent behavior)
  • Cardiac or intracranial surgery (due to competing causes of delirium)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Family-Augmented Hospital Elder Life Program (FAM-HELP)FAM-HELPThe FAM-HELP program will incorporate a family member and/or care partner, who will play a central role with providing bedside support for delirium risk reduction. Family members and care partners will provide social and emotional support along with augmentation of HELP-based protocols.
Hospital Elder Life Program (HELP)HELPHospital Elder Life Program (HELP) is built upon multicomponent, non-pharmacologic strategies that target delirium risk factors to optimize cognitive and clinical function during hospitalization.
Primary Outcome Measures
NameTimeMethod
Delirium IncidenceDay of trial enrollment through day of hospital discharge, up to 14 days

Any positive delirium screen (yes/no) as determined by the long-form Confusion Assessment Method (CAM), supplemented by a validated chart review approach for delirium.

Delirium SeverityDay of trial enrollment through day of hospital discharge, up to 14 days

Delirium severity will be scored using the Confusion Assessment Method Long Form Severity Score (CAM-S) (n, 0-19, with higher number indicating more severe delirium). Score derived from the same CAM instrument and items used for delirium incidence.

Secondary Outcome Measures
NameTimeMethod
Delirium DurationDay of trial enrollment through day of hospital discharge, up to 14 days

The cumulative number of days (n) with a positive delirium screen will be calculated for all participants

Persistent Delirium30 days after hospital discharge

Positive delirium screen (yes/no) 30 days after hospital discharge as determined by the long-form Confusion Assessment Method (AM)

Delirium Burden - PatientDay of trial enrollment through 30 days after discharge

Delirium burden will be calculated using the Patient Delirium Burden Scale (DEL-B-P) (n, 0-40, with higher number indicating more severe burden)

Delirium Burden - Family and Care PartnersDay of trial enrollment through 30 days after discharge

Delirium burden will be calculated using the Patient Delirium Family Caregiver Scale (DEL-B-C) (n, 0-40, with higher number indicating more severe burden)

Caregiving StrainHospital discharge through 30 days after discharge

Strain associated with patient caregiving will be assessed via Modified Caregiver Strain Index (MCSI) (n, 0-26, with higher number indicating more caregiver strain)

FallsDay of trial enrollment through 30 days after hospital discharge

Proportion of participants in each group (%) experiencing at least one fall

Cognitive Function - Subjective ReportingHospital discharge through 30 days after discharge

Subjective reporting of cognitive function will be assessed via PROMIS Cognitive Function - Short Form 6a (n, 6-30, with higher number indicating better subjective cognitive function)

Physical Function30 days after hospital discharge

Assessment of physical function via PROMIS Physical Short Form 10a (n, 10-50, with higher scores indicating better physical function).

Hospital ExperienceDay of hospital discharge (typically up to 30 days after hospital admission, may extend to 60 or more days)

Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) Survey (n, 7-28, with higher score indicating better hospital experience)

Global HealthHospital discharge through 30 days after discharge

Assessment of overall physical and mental health via PROMIS Global Health-10. Two separate subscales will be calculated, Global Physical Health (n, 4-20) and Global Mental Health (n, 4-20), with higher scores indicating better health.

Discharge DispositionDay of hospital discharge through 30 days after discharge

Proportion of patients in each group (%) discharged somewhere other than home (e.g., Long-Term Care Facility)

Length of Hospital StayDay of hospital admission through hospital discharge (typically up to 30 days after hospital admission, may extend to 60 or more days)

Total number of days (n) spent in the hospital

30-Day ReadmissionDay of hospital discharge through 30 days after discharge

Proportion of participants in each group (%) requiring hospital readmission

Trial Locations

Locations (7)

Saddleback Medical Center

🇺🇸

Orange, California, United States

MaineHealth

🇺🇸

Portland, Maine, United States

Michigan Medicine

🇺🇸

Ann Arbor, Michigan, United States

Hospital of the University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

Allegheny General Hospital

🇺🇸

Pittsburg, Pennsylvania, United States

University of Utah

🇺🇸

Salt Lake City, Utah, United States

Meriter Hospital

🇺🇸

Madison, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath